Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
2.110
+0.070 (3.43%)
At close: Nov 21, 2024, 4:00 PM
2.102
-0.008 (-0.39%)
After-hours: Nov 21, 2024, 5:46 PM EST
Immuneering Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -58.07 | -53.47 | -50.51 | -33.54 | -17.04 | -7.71 |
| Depreciation & Amortization | 0.39 | 0.35 | 0.8 | 0.16 | 0.08 | 0.02 |
| Loss (Gain) From Sale of Assets | 0 | 0 | 0.01 | - | - | - |
| Loss (Gain) From Sale of Investments | -0.61 | -1.02 | -0.17 | 0.13 | - | - |
| Stock-Based Compensation | 6.42 | 5.73 | 4.06 | 1.8 | 1.09 | 0.6 |
| Other Operating Activities | 0.34 | 0.41 | - | -0.31 | - | 2.22 |
| Change in Accounts Receivable | - | 0.01 | 0.23 | 0.28 | -0.29 | 0.61 |
| Change in Accounts Payable | 0 | -1.11 | 1.76 | -0.13 | 1.19 | 0.27 |
| Change in Unearned Revenue | - | - | - | - | - | -0.47 |
| Change in Other Net Operating Assets | -0.74 | 0.12 | -0.28 | 0.75 | 0.36 | 0.02 |
| Operating Cash Flow | -52.26 | -48.97 | -44.1 | -30.85 | -14.62 | -4.44 |
| Capital Expenditures | -0.25 | -0.34 | -0.74 | -0.06 | -0.05 | -0.02 |
| Cash Acquisitions | - | - | - | 0.07 | - | - |
| Investment in Securities | 24.32 | 7.64 | 42.57 | -75.63 | - | - |
| Investing Cash Flow | 24.08 | 7.3 | 41.83 | -75.62 | -0.05 | -0.02 |
| Short-Term Debt Issued | - | - | - | - | - | 3.83 |
| Total Debt Issued | - | - | - | - | - | 3.83 |
| Net Debt Issued (Repaid) | - | - | - | - | - | 3.83 |
| Issuance of Common Stock | 5.35 | 28.64 | 0.3 | 121.6 | - | - |
| Other Financing Activities | - | -0.2 | -0.28 | -2.12 | - | -0.06 |
| Financing Cash Flow | 5.35 | 28.44 | 0.02 | 144.26 | 37.98 | 17.17 |
| Net Cash Flow | -22.83 | -13.23 | -2.25 | 37.8 | 23.31 | 12.71 |
| Free Cash Flow | -52.51 | -49.31 | -44.84 | -30.91 | -14.67 | -4.46 |
| Free Cash Flow Margin | - | - | -14148.44% | -1486.17% | -634.83% | -232.48% |
| Free Cash Flow Per Share | -1.78 | -1.74 | -1.70 | -2.27 | -2.96 | -0.90 |
| Levered Free Cash Flow | -32.75 | -31.1 | -25.99 | -18.59 | -8.25 | - |
| Unlevered Free Cash Flow | -32.75 | -31.1 | -25.99 | -18.59 | -8.25 | - |
| Change in Net Working Capital | -0.01 | 0.33 | -2.23 | -0.69 | -1.31 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.